Grape King Bio Ltd (1707)

Currency in TWD
120.00
-1.00(-0.83%)
Closed·
Unusual trading volume
High dividend Yield
1707 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
119.00121.00
52 wk Range
117.50139.00
Key Statistics
Bid/Ask
168.00 / 168.50
Prev. Close
141
Open
120.5
Day's Range
119-121
52 wk Range
117.5-139
Volume
271.63K
Average Volume (3m)
121.92K
1-Year Change
-9.434%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1707 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
138.00
Upside
+15.00%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Grape King Bio Ltd News & Analysis

Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company provides health products and supplements; and microbial fermentation for mushroom mycelium, probiotics, and enzymes. It also offers functional ingredients for intestinal care, immunity regulation, liver care, brain health, eye care, weight control, feminine health, sensual health care, and others. It serves pharmaceutical preparations, finished drugs, oral liquids, and beverages and health foods. The company was founded in 1969 and is headquartered in Taoyuan City, Taiwan.

Employees
501
Market
Taiwan

Compare 1707 to Peers and Sector

Metrics to compare
1707
Peers
Sector
Relationship
P/E Ratio
14.7x17.8x12.3x
PEG Ratio
−0.930.120.03
Price/Book
1.7x1.8x1.5x
Price / LTM Sales
1.7x1.5x0.9x
Upside (Analyst Target)
14.0%0.2%21.6%
Fair Value Upside
Unlock11.3%10.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 138.00
(+15.00% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 8.17%
Dividend Yield
4.96%
Industry Median 4.17%
Annualized payout
6.00
Paid annually
5-Years Growth
-1.28%
Growth Streak

Earnings

Latest Release
Mar 04, 2026
EPS / Forecast
2.84 / 3.42
Revenue / Forecast
3B / 3.42B
EPS Revisions
Last 90 days

1707 Income Statement

FAQ

What Is the Grape King Bio (1707) Stock Price Today?

The Grape King Bio stock price today is 120.00 TWD.

What Stock Exchange Does Grape King Bio Trade On?

Grape King Bio is listed and trades on the Taiwan Stock Exchange.

What Is the Stock Symbol for Grape King Bio?

The stock symbol for Grape King Bio is "1707."

Does Grape King Bio Pay Dividends? What’s The Current Dividend Yield?

The Grape King Bio dividend yield is 4.92%.

What Is the Grape King Bio Market Cap?

As of today, Grape King Bio market cap is 17.78B TWD.

What Is Grape King Bio's Earnings Per Share (TTM)?

The Grape King Bio EPS (TTM) is 8.17.

When Is the Next Grape King Bio Earnings Date?

Grape King Bio will release its next earnings report on May 07, 2026.

From a Technical Analysis Perspective, Is 1707 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Grape King Bio Stock Split?

Grape King Bio has split 4 times.

How Many Employees Does Grape King Bio Have?

Grape King Bio has 501 employees.

What is the current trading status of Grape King Bio (1707)?

As of Apr 11, 2026, Grape King Bio (1707) is trading at a price of 120.00 TWD, with a previous close of 141.00 TWD. The stock has fluctuated within a day range of 119.00 TWD to 121.00 TWD, while its 52-week range spans from 117.50 TWD to 139.00 TWD.

What Is Grape King Bio (1707) Price Target According to Analysts?

The average 12-month price target for Grape King Bio is 138.00 TWD, with a high estimate of 138 TWD and a low estimate of 138 TWD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +15.00% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.